25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hypoparathyroidism mimicking ankylosing spondylitis and myopathy: a case report

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          INTRODUCTION Idiopathic hypoparathyroidism (HP) is an induced or inherited condition characterized by insufficient secretion of parathyroid hormone. The clinical manifestations of this condition are varied, and pain and stiffness affecting the back and hips resembling ankylosing spondylitis is an under-recognized symptom in these patients. Here, we report a case of delayed diagnosis of hypoparathyroidism referred to a rheumatologist due to progressive inflammatory back pain and myalgia. Idiopathic hypoparathyroidism is an induced or inherited condition of unknown etiology and is characterized by insufficient secretion of parathyroid hormone due to atrophy or absence of parathyroid glands, which leads to hypocalcaemia and hyperphosphatemia.1 Hypoparathyroidism has multiple clinical manifestations, which primarily involve tissues of ectodermic origin.2 Pain and stiffness affecting the back and hips, limited movement and posture resembling that seen in patients with ankylosing spondylitis is an under-recognized feature in patients with this condition.1,3 Muscular complaints by these patients are common because the concentration of calcium ions is important for the maintenance and control of several biochemical processes during muscle contraction. Hypocalcaemia causes hyperexcitability of nerves and muscles, and a sporadic increase in muscular enzymes.4 Here, we report a case of delayed diagnosis of hypoparathyroidism referred to a rheumatologist due to progressive inflammatory back pain and myalgia with concomitant elevation of inflammatory markers and muscle enzymes. The patient was initially erroneously diagnosed with ankylosing spondylitis (AS) and idiopathic myopathy. This case reinforces the relevance of investigating the underlying mineral metabolism disturbances in patients with inflammatory diseases. CASE REPORT A 40-year-old man was referred to the Rheumatology Outpatient Clinic with a fifteen-year history of progressive inflammatory back and neck pain and prolonged (two hours) morning stiffness. He also complained of diffuse myalgia, muscle cramps, and frequent changes in bowel habits characterized by chronic diarrhea (intermittent liquid diarrhea without abdominal pain, mucous or blood, usually occurring after meals). He reported a history of epilepsy since three months of age and cataracts by age 31. He had no history of surgical excision or damage to the parathyroid gland, radiation or neoplastic/granulomatosis infiltration. He also denied consanguinity, Arab ancestry, deafness or recurrent oral candidiasis. Upon physical examination, the patient displayed a typical AS posture with decreased spinal mobility, a neck rotation of 10°, chest expansion of 1.5 cm, and a Schöber test measurement of 10.5 cm. His hip movement was markedly restricted in all directions, particularly flexion and rotation. The Fabere test was positive. The patient fulfilled the modified New York criteria for ankylosing spondylitis.5 Assessment of the patient's muscle strength revealed Grade IV reduction in all four limbs. Trousseau's and Chvostek's signs also gave negative results. The patient had dental abnormalities and a cognitive deficit (two years' education and a Mini-Mental State Examination score of eight), but cleft palate, growth retardation, microcephaly, microphthalmia, and small hands and feet were not observed. Dental abnormalities on a panoramic X-Ray revealed few erupted teeth and the presence of multiple impacted teeth in the maxilla and mandible, producing a change in anatomical size and shape. Laboratory investigation revealed hypocalcaemia (calcium 4 mg/dL, ionized calcium 2.3 mg/dl), hyperphosphatemia (5.3 mg/dl), undetectable parathyroid hormone (<3 pg/ml) and vitamin D levels within the normal range (56.1 ng/ml). Inflammatory markers (CRP 29.9 mg/dl and ESR 31 mm) and muscle enzymes (CPK 2805 U/l, aldolase 8.6 U/l and lactic dehydrogenase 1397 U/l) were elevated (Table 1). The patient did not express HLA-B27. Tests for anti-nuclear antibodies and rheumatoid factor were negative. The patient's thyroid hormones, serum, and urinary cortisol were normal. Blood counts and glucose, urea and creatinine levels were also within normal ranges. Serology for viral hepatitis, syphilis, HIV, and HTLV were negative. Echocardiogram and renal ultrasound were normal. A brain CT scan revealed calcifications in the basal ganglia, thalamus, and cerebellum. A mandibular panoramic radiograph confirmed hypoplasia and dental malformations. Electromyography was normal. Bone fusions in the cervical spine, calcification of ligaments and syndesmophytes in the lumbar spine were observed through spine radiography (Figure 1), and Grade II (right)/Grade III (left) sacroiliitis was observed through sacroiliac joint radiography. Computed tomography (CT) revealed ankylosis foci at the sacroiliac joint (SI) and bilateral ossification of the iliolumbar ligament (Figure 2B). Similarly, magnetic resonance imaging demonstrated ossification of the iliosacral ligaments in the lower portions of the sacroiliac joints and no significant findings in the upper portions of the SI joint (Figure 2C). Bone mineral density evaluated by DXA revealed a Z-score of +4.4 SD at the lumbar spine, -0.2 SD at the total femur and -1.0 SD at the femoral neck. Treatment with 2 g/day calcium carbonate and 1 µg calcitriol led to evident clinical and laboratory improvement including normalization of the bowel habits. Increasing the calcium dose to 4 g/day was recommended. At the following visit, the patient had stopped taking the medicine, and the laboratory parameters consequently worsened, particularly inflammatory markers and muscle enzymes (Table 1). The importance of treatment adherence was reinforced, and calcium supplements were increased to 6 g/day, normalizing the serum calcium and muscle enzymes and reducing inflammatory markers. Concomitant improvement of neck and back pain, disappearance of the cramps and muscle pain and normalization of bowel habits were observed. DISCUSSION To our knowledge, this is the first case report of idiopathic HP simulating AS associated with idiopathic myopathy. The diagnosis of HP was confirmed by hypocalcemia, hyperphosphatemia, and undetectable PTH. The chronic development of hypocalcemia may explain the absence of tetany in this case. In fact, the most prominent symptoms of tetany usually occur in acute forms of hypocalcemia and the development of tetany symptoms depends on the duration, severity, and rapidity of hypocalcemia.6 Developmental disorders are unlikely in this case because the patient did not exhibit the typical characteristics of DiGeorge Syndrome/Catch-22,7 hypoparathyroidism-sensorineural deafness-renal dysplasia syndrome,8 hypoparathyroidism-retardation-dysmorphism or Kenny-Caffey syndromes.9 Parathyroid gland destruction was excluded given that the patient did not have a history of surgical excision or radiation therapy. The patient had no family history or clinical features suggestive of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.10 Autoimmune adrenal involvement was also excluded as the serum and urinary parameters were within normal ranges and clinical symptoms were absent. In addition, the classic triad of Kearn-Sayres syndrome (KSS) was not observed, and the muscle complaints began late in life.11 Based on the above evidence, the probable diagnosis is idiopathic HP, although other rare defects cannot be excluded because specific genetic analyses were not performed. Occasionally, patients with HP may have clinical and radiologic characteristics resembling AS1 due to paravertebral calcification and ossification12. The syndesmophyte in our HP patient, which exhibited the origination in the vertebral margin and preservation of disc space characteristic of AS, led to the misdiagnosis of AS. This finding is distinct from osteoarthritis in which osteophytes are horizontal and there is a significant reduction in disc space.13 The predominant localization in the lumbar region also suggested the diagnosis of AS, although any spinal location may be involved in HP.13 Diffuse idiopathic skeletal hyperostosis (DISH) was unlikely, considering the radiologic spine features, the early appearance of calcifications (before the fourth decade) and the absence of co-morbidities such as dyslipidemia and diabetes mellitus type 2.12 The radiographic findings in the sacroiliac joint were predominant in the lower portion with ossification of the iliolumbar ligament, whereas the involvement is more common in the upper region of the joint in AS. In addition, the evident ossification at the hip joint with preserved joint space is not characteristic of AS but has been reported in HP.1 Moreover, the lack of HLA-B27 expression may reduce the likelihood of the AS diagnosis as over 90% of AS patients are positive for this allele,13 although no data regarding the frequency of HLA-B27 in the healthy Brazilian population are available. Of note, the extensive basal ganglia calcification in our case has been reported more often in HP patients with spine involvement than in those without this complication,13 suggesting a disseminated process of calcification associated with mineral metabolism disturbance. Reinforcing this possibility, long-term HP disease was more often associated with spinal involvement,13 which was also observed in the patient evaluated herein. In addition, there is much in vitro evidence that hyperphosphatemia may have a proinflammatory role14 that could ultimately contribute to the calcification observed in our patient. The novel description of concomitant association of HP and spondyloarthritis with myopathy was supported by the diminished muscle strength and marked muscle enzyme elevations. Chronic hypocalcemic myopathy secondary to HP and raised serum CK concentration has rarely been reported15 and is probably an under-recognized condition due to the patient's adaptation to long-standing hypocalcemia. The most likely explanation of this condition is that the increased permeability of the muscle membrane induced by hypocalcemia leads to CK release.16 The inverse correlation between CK and serum calcium concentrations as well as the normal electromyographic findings observed in this case support this possibility. Of note, rhabdomyolysis was excluded due to normal urine analysis, the absence of acute renal failure and the positive response to calcium treatment. Idiopathic HP has been described as an unusual cause of diarrhea17 as observed in the present case. Reinforcing this possibility, the bowel habits were normalized after hypocalcemia correction. Importantly, the clinical and laboratory improvements achieved solely with calcium and calcitriol supplementation confirmed the diagnosis of HP and excluded the associations with ankylosing spondylitis and idiopathic myopathy, as inflammatory rheumatic diseases are unresponsive to this therapy. This case emphasizes the importance of recognizing rheumatic manifestations of HP to preclude unnecessary treatments. HP should be considered in the differential diagnosis of spondyloarthropathies and myopathies, and calcium may be included in the diagnostic workup of these patients.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          HDR syndrome: a novel "de novo" mutation in GATA3 gene.

          Human GATA3 haploinsufficiency leads to HDR (hypoparathyroidism, deafness, and renal dysplasia) syndrome. The development of a specific subset of organs in which this transcription factor is expressed appears exquisitely sensitive to gene dosage. We report on a 14-year-old patient with symptomatic hypoparathyroidism, sensorineural bilateral deafness, unilateral renal dysplasia, bilateral palpebral ptosis, and horizontal nystagmus. Fundoscopy displayed symmetrical pseudopapilledema, and brain CT scan revealed basal ganglia calcifications. FISH analysis did not disclose any microdeletion in the 22q11.2 or 10p14 regions. GATA3 mutation analysis identified a heterozygous deletion of GG nucleotides at codon 36 and 37 (c.108_109delGG) in exon 2 causing a frameshift with a premature stop codon after a new 15-aminoacid sequence. Restriction endonuclease analysis performed in parents was negative. Our patient carries a novel "de novo" GATA3 mutation, providing further evidence that HDR syndrome is caused by haploinsufficiency of GATA3, which may be responsible for a complex neurologic picture besides the known triad.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

            Accumulating evidence implicates T(H)17 cytokines in protection against Candida species infections, but the clinical relevance is not clear. Chronic mucocutaneous candidiasis (CMC) is a heterogeneous syndrome with the unifying feature of selective susceptibility to chronic candidiasis. Different subgroups with distinct clinical features are recognized, including autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), CMC with hypothyroidism, and isolated CMC. Understanding immune defects in patients with CMC will define cellular and molecular mechanisms crucial for protection against Candida species in human subjects. We sought to determine whether impaired T(H)17 responses underlie susceptibility to Candida species infections and whether the same defect is present in different CMC subgroups. We assessed T(H)17 responses of PBMCs to Candida and non-Candida species stimuli by measuring IL-17, IL-22, IL-21, IL-6, IL-23, and IFN-γ cytokine production using cytokine arrays and intracellular cytokine-producing cell numbers and proliferation with flow cytometry. PBMCs from healthy subjects and unaffected family members served as controls. In patients with CMC with hypothyroidism, T(H)17 cells demonstrated decreased proliferation and IL-17 production in response to Candida species. In contrast, in patients with APECED, T(H)17 cell proliferation and IL-17 production were normal unless exposed to APECED plasma, which inhibited both functions in both APECED and normal PBMCs. Candida species-stimulated IL-22 production was impaired in all patients with CMC, whereas IL-6 and IL-23 responses were unaltered. An impaired T(H)17 response to Candida species, although mediated by different mechanisms, was present in all CMC subgroups studied and might be a common factor predisposing to chronic candidiasis. Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Presence of spondyloarthropathy and its clinical profile in patients with hypoparathyroidism.

              Though spondyloarthropathy has been described in patients with sporadic idiopathic hypoparathyroidism (SIH), the clinical profile is not known. To describe the clinical profile including radiological features of spondyloarthropathy and prevalence of HLA-B27 allele in patients with hypoparathyroidism, and to identify any differences from ankylosing spondylitis. Clinical characteristics and radiographs of pelvis and spine were assessed in 40 consecutive patients with SIH. Radiographs were assessed by radiologist (RS) and rheumatologist (RG) for the features of spondyloarthropathy including sacroiliitis, syndesmophytes and hip joint calcification, and so on. HLA-B27 genotyping was carried out in patients with SIH, and 195 healthy controls using duplex PCR. Fourteen control radiographs were from age-matched normal individuals. Three patients with SIH had clinically overt spondyloarthropathy which closely resembled ankylosing spondylitis. Fourteen (eight females and six males) of the 40 patients with SIH showed radiological changes including syndesmophytes in lower dorsal or dorso-lumbar spine (n = 6), sacroiliitis and new bone formation at the acetabular rim of the hip joint (n = 10). Though all six patients demonstrating syndesmophytes had new bone formation at hip, sacroiliitis was seen in only three of them. None of the 14 controls had syndesmophytes, sacroiliitis or hip joint calcification. The mean (SD) duration of illness (15.4 +/- 8.7 vs. 6.5 +/- 5.9 years, P < 0.01), BMI (24.1 +/- 5.2 vs. 20.8 +/- 3.7 kg/m(2), P = 0.04) and frequency of basal ganglia calcification was higher (100%vs. 57.7%, P < 0.01) in patients who showed changes of spondyloarthropathy in comparison to those without these changes. On multiple logistic regression analysis, only duration of hypoparathyroid illness was associated with spondyloarthropathy with an odds ratio of 1.17 (95% CI = 1.05-1.30, P < 0.01) per year increase in the duration. The mean age, serum total calcium, inorganic phosphorus and serum intact PTH (iPTH) levels were not significantly different between SIH patients with and without spondyloarthropathy. The frequency of HLA-B27 allele was comparable between SIH and the control groups. Thus, spondyloarthropathy is a distinct clinical entity in patients with SIH. Its salient clinical features include presence of syndesmophytes at the thoracic or thoraco-lumbar spine, mild sacroiliitis, calcification at the acetabular margin of hip, preserved bone density, equal distribution in both sexes and lack of HLA-B27 association. Presence of spondyloarthropathy, like basal ganglia calcification, is associated with longer duration of hypoparathyroidism. It is important to differentiate hypoparathyroid-related spondyloarthropathy from ankylosing spondylitis because the management for the two disorders is different.
                Bookmark

                Author and article information

                Journal
                Clinics (Sao Paulo)
                Clinics
                Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
                1807-5932
                1980-5322
                July 2011
                : 66
                : 7
                : 1287-1290
                Affiliations
                Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo/SP, Brazil.
                Author notes
                Email: rosamariarp@ 123456yahoo.com Tel.: 55 11 3061-7213
                Article
                cln_66p1287
                10.1590/S1807-59322011000700028
                3148479
                21876989
                a932cf46-a7f3-4f51-9941-7fc308fece25
                Copyright © 2011 Hospital das Clínicas da FMUSP

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Page count
                Pages: 4
                Categories
                Case Report

                Medicine
                Medicine

                Comments

                Comment on this article